MSCI (MSCI) Competitors

MSCI (NYSE:MSCI) and CME Group (NASDAQ:CME) are both large-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, community ranking, risk, analyst recommendations, media sentiment, earnings and profitability.

Is MSCI or CME more profitable?

CME Group has a net margin of 57.52% compared to MSCI's net margin of 38.83%. CME Group's return on equity of 13.62% beat MSCI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MSCI	38.83%	-156.08%	22.03%
CME Group	57.52%	13.62%	2.81%

Do insiders and institutionals have more ownership in MSCI or CME?

90.0% of MSCI shares are held by institutional investors. Comparatively, 87.8% of CME Group shares are held by institutional investors. 3.3% of MSCI shares are held by insiders. Comparatively, 0.3% of CME Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Does the MarketBeat Community prefer MSCI or CME?

CME Group received 121 more outperform votes than MSCI when rated by MarketBeat users. However, 65.99% of users gave MSCI an outperform vote while only 58.59% of users gave CME Group an outperform vote.

Company	Underperform	Outperform
MSCI	Outperform Votes 551 65.99%	Underperform Votes 284 34.01%
CME Group	Outperform Votes 672 58.59%	Underperform Votes 475 41.41%

Is MSCI or CME a better dividend stock?

MSCI pays an annual dividend of $7.20 per share and has a dividend yield of 1.3%. CME Group pays an annual dividend of $5.00 per share and has a dividend yield of 1.8%. MSCI pays out 49.5% of its earnings in the form of a dividend. CME Group pays out 50.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. MSCI has increased its dividend for 11 consecutive years.

Which has better earnings and valuation, MSCI or CME?

CME Group has higher revenue and earnings than MSCI. CME Group is trading at a lower price-to-earnings ratio than MSCI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MSCI	$2.92B	14.47	$1.11B	$14.55	37.57
CME Group	$6.28B	15.89	$3.53B	$9.94	27.88

Which has more risk & volatility, MSCI or CME?

MSCI has a beta of 1.3, suggesting that its share price is 30% more volatile than the S&P 500. Comparatively, CME Group has a beta of 0.43, suggesting that its share price is 57% less volatile than the S&P 500.

Does the media favor MSCI or CME?

In the previous week, CME Group had 13 more articles in the media than MSCI. MarketBeat recorded 47 mentions for CME Group and 34 mentions for MSCI. MSCI's average media sentiment score of 0.96 beat CME Group's score of 0.85 indicating that MSCI is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MSCI	24 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
CME Group	30 Very Positive mention(s)	2 Positive mention(s)	9 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts prefer MSCI or CME?

MSCI presently has a consensus price target of $645.36, suggesting a potential upside of 18.07%. CME Group has a consensus price target of $256.80, suggesting a potential downside of 7.33%. Given MSCI's stronger consensus rating and higher probable upside, equities research analysts clearly believe MSCI is more favorable than CME Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MSCI	0 Sell rating(s)	3 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.77
CME Group	3 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.25

Summary

MSCI beats CME Group on 13 of the 22 factors compared between the two stocks.